QA: Clovis Oncology Inc in us_pharma/2017

Table of Contents

See also this year's filing and all EDGAR filings for this company.

PDF Report 0001466301_2018_Clovis_Oncology_Inc.pdf

Logs

warning The stock price does not exist industry.us_generic {}

Graph

Absolute values for 0001466301, Clovis Oncology Inc

  xvar xval
0 AssetsCurrent 626,940,000
1 IntangibleAssetsNetIncludingGoodwill 84,778,000
2 PropertyPlantAndEquipmentNet 4,007,000
3 remainder_Assets 19,505,000
4 LiabilitiesCurrent 81,517,000
5 LiabilitiesNoncurrent 0
6 remainder_Liabilities 286,077,000
7 CostOfGoodsAndServicesSold 0
8 SellingGeneralAndAdministrativeExpense 145,867,662
9 ResearchAndDevelopmentExpense 173,438,122
10 remainder_Expenses 20,469,931
11 remainder_Revenues 332,676,000
12 remainder_NetIncome -126,554,676
13 remainder_ComprehensiveNetIncome 5,106,178
  yvar yval
0 Assets 735,230,000
1 Liabilities 367,594,000
2 Expenses 339,775,715
3 Revenues 332,676,000
4 StockholdersEquity 367,636,000
5 NetIncome -133,654,391
6 ComprehensiveNetIncome -131,101,302
7 BaseVar 953,468,284
8 EconomicCapitalRatiobeforeLimitedLiability 1.22
9 EconomicCapitalRatio 2.47

Edgar->Model Mapping

Feature Distribution

Change over Time